CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-10 | Innoviva, Inc. Director | Purchase · Convertible Debt convertible into Common Stock | +0 | $30,000,000.00 | $0 | |
| 2022-03-31 | Innoviva, Inc. Director | Purchase | +5,385,208 | $5.00 | $26.9M | 16,365,969 |
| 2022-03-31 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +0 | $5.00 | $0 | 2,692,604 |
| 2022-02-09 | Innoviva, Inc. Director | Purchase | +3,614,792 | $5.00 | $18.1M | 10,980,761 |
| 2022-02-09 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +1,807,396 | $5.00 | $9.0M | 1,807,396 |
| 2021-10-29 | Innoviva, Inc. Director | Purchase | +1,212,122 | $3.30 | $4.0M | 7,365,969 |
| 2021-03-17 | Innoviva, Inc. Director | Purchase | +4,285,935 | $3.25 | $13.9M | 6,153,847 |
| 2021-03-17 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +4,285,935 | $3.25 | $13.9M | 6,153,847 |
| 2021-01-26 | Innoviva, Inc. Director | Purchase | +1,867,912 | $3.25 | $6.1M | 1,867,912 |
| 2021-01-26 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +1,867,912 | $3.25 | $6.1M | 1,867,912 |
| 2020-03-27 | Innoviva, Inc. 10% owner | Purchase | +7,717,661 | $2.87 | $22.1M | 8,710,800 |
| 2020-03-27 | Innoviva, Inc. 10% owner | Purchase · Warrants to Acquire Common Stock | +7,717,661 | $2.87 | $22.1M | 8,710,800 |
Page 1 of 1 · 12 trades